Integra LifeSciences Holdings Corporation
Organization details
- Legal name
- Integra LifeSciences Holdings Corporation
- Former names
- Integra Lifesciences Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Princeton
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IART
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000917520
- EIN
- 51-0317849
Board of directors
-
Barbara B. Hill · DirectorSince 2023
-
Christian S. Schade · DirectorSince 2023
-
Jeffrey A. Graves · DirectorSince 2023
-
Keith Bradley · DirectorSince 2023
-
Mojdeh Poul · Director · President & CEOSince 2025
-
Raymond G. Murphy · DirectorSince 2023
-
Renee Wonlai Lo · DirectorSince 2023
-
Shaundra Clay · DirectorSince 2023
-
Stuart Essig · Director · President and CEOSince 2023
-
Witte Jan De · Director · President & CEOSince 2023
Chief executives
Mixed · grade D
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 47
1.5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of May 7, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
93.7%
-
95.0%
-
98.4%
-
98.5%
-
99.0%
-
99.6%
Board connections
5 of this board's directors also sit on 10 other boards. 5 are in the same sector.
- via Jeffrey A. Graves
-
Align Technology Inc. Same sectorvia Mojdeh Poul
- via Jeffrey A. Graves
-
IDEXX Laboratories Inc. Same sectorvia Stuart Essig
- via Barbara B. Hill
-
Orthofix Medical Inc. Same sectorvia Stuart Essig
- via Stuart Essig
-
ResMed Inc. Same sectorvia Witte Jan De
- via Mojdeh Poul
-
iRhythm Holdings Inc. Same sectorvia Mojdeh Poul
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Veillon-Berteloot Chantal Officer (EVP & CHRO) | Shares withheld for tax | −1,455 | $16.62 | $24,182 |
| Jul 3, 2026 | Knight Lea Daniels Officer (EVP & Chief Financial Officer) | Shares withheld for tax | −5,226 | $18.05 | $94,329 |
| Jul 1, 2026 | Mosebrook Jeffrey Officer (SVP, Fin & Princ Acct Officer) | Shares withheld for tax | −937 | $17.89 | $16,763 |
| May 9, 2026 | Keith Bradley Director | Shares withheld for tax | −882 | $13.92 | $12,277 |
| May 7, 2026 | Barbara B. Hill Director | Grant or award | +6,638 | — | — |
| May 7, 2026 | Barbara B. Hill Director | Grant or award | +17,700 | — | — |
| Mar 11, 2026 | Knight Lea Daniels Officer (EVP & Chief Financial Officer) | Shares withheld for tax | −8,089 | $9.61 | $77,735 |
| Mar 11, 2026 | Veillon-Berteloot Chantal Officer (EVP & CHRO) | Shares withheld for tax | −5,420 | $9.61 | $52,086 |
| Mar 11, 2026 | McBreen Michael J. Officer (EVP & President, CSS) | Shares withheld for tax | −7,247 | $9.61 | $69,644 |
| Mar 11, 2026 | DAVIS ROBERT T. JR. Officer (EVP & President, TT) | Shares withheld for tax | −8,487 | $9.61 | $81,560 |
| Mar 11, 2026 | Mosebrook Jeffrey Officer (SVP, Fin & Princ Acct Officer) | Shares withheld for tax | −806 | $9.61 | $7,746 |
| Mar 11, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Shares withheld for tax | −861 | $9.61 | $8,274 |
| Mar 11, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Option exercise | +18,922 | — | — |
| Mar 11, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Shares withheld for tax | −5,190 | $9.61 | $49,876 |
| Mar 10, 2026 | Singh Harvinder Officer (EVP & PRESIDENT, INTERNATIONAL) | Option exercise | +1,216 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Integra LifeSciences Holdings Corporation
Who is the CEO of Integra LifeSciences Holdings Corporation?
Mojdeh Poul has been Integra LifeSciences Holdings Corporation's President & CEO since January 2025.
How many directors are on Integra LifeSciences Holdings Corporation's board?
Integra LifeSciences Holdings Corporation's board has 10 directors: Barbara B. Hill, Christian S. Schade, Jeffrey A. Graves, Keith Bradley, Mojdeh Poul, Raymond G. Murphy, Renee Wonlai Lo, Shaundra Clay, Stuart Essig and Witte Jan De.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="integra-lifesciences-holdings-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.